Its role in ADPR production suggests the potential involvement of CD157 in the CD38/CD157/CD203a/CD73 adenosinergic pathway [35], which as aforementioned, results in increased adenosine levels and an immunosuppressive TME that favors tumor progression [18,19]. Here, CD38 is linked to neoplasm.